Omega-3-Fettsäuren bei Krebserkrankungen

Newell M et al. N-3 long-chain polyunsaturated fatty acids, eicosapentaenoic and docosahexaenoic acid, and the role of supplementation during cancer treatment: A scoping review of current clinical evidence. Cancers (Basel) 2021; 13: 1206. doi: 10.3390/cancers13061206

Publikationsverlauf

Artikel online veröffentlicht:
08. Dezember 2021

• Literatur

• 1 Katzler O. Omega-3-Fettsäuren in der Behandlung der gynäkologischen Onkologie. Deutsche Zeitschrift für Onkologie 2021; 53: 172-174
• 2 Muecke R, Schomburg L, Glatzel M. et al.; German Working Group Trace Elements and Electrolytes in Oncology-AKTE. Multicenter, phase 3 trial comparing selenium supplementation with observation in gynecologic radiation oncology. Int J Radiat Oncol Biol Phys 2010; 78: 828-835
• 3 Miyauchi A. Clinical trials of active surveillance of papillary microcarcinoma of the thyroid. World J Surg 2016; 40: 516-522
• 4 Coleman R, Bundred N, De Boer R, Llombarto A. et al. Impact of zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole: Z-FAST, ZO-FAST and E-ZO-FAST. Cancer Res. 2009 69 (24 Supplement): 4082